Archive

Cape Town biotech firm Afrigen’s business rescue begins as the WHO-backed mRNA hub seeks new investment to secure vaccine manufacturing.

The pause in NHI Act implementation opens a window to improve South Africa’s healthcare infrastructure. Discover its implications.

Examine the consequences of the Global Funding Crisis on multilateral health institutions and their role in global health equity.

Health Minister Aaron Motsoaledi confirms suspensions in the Health Department after fraud arrests involving the Global Fund.

Learn about potential Aspen Pharmacare asset disposals aimed at optimising the company’s global operations for greater profitability.

Across South Africa and the globe, a silent scourge is devastating public health. Chronic respiratory diseases (CRDs), including asthma and chronic obstructive pulmonary disease (COPD), remain significantly underreported. Despite their prevalence, they receive far less attention than infectious diseases.

The GEMS contribution increases have sparked tensions with public-sector unions. Discover the details surrounding this issue.

Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.

Learn how the new FDA biosimilar development guidance can significantly lower biologic medicine costs and improve accessibility.

The NHI corruption risks are exposed in light of bribery cases, raising concerns for the future of healthcare in South Africa.

Understand the current status of NHI preparations in South Africa, including government strategies and ongoing legal challenges.